Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Biallelic ATOH1 Gene Variant in Siblings With Pontocerebellar Hypoplasia, Developmental Delay, and Hearing Loss.
Neurol Genet. 2022 May 3;8(3):e677. doi: 10.1212/NXG.0000000000000677. eCollection 2022 Jun.
Neurol Genet. 2022.
PMID: 35518571
Free PMC article.
Effects of Repetitive Transendocardial CD34+ Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy.
Vrtovec B, Poglajen G, Sever M, Zemljic G, Frljak S, Cerar A, Cukjati M, Jaklic M, Cernelc P, Haddad F, Wu JC.
Vrtovec B, et al.
Circ Res. 2018 Jul 20;123(3):389-396. doi: 10.1161/CIRCRESAHA.117.312170. Epub 2018 Jun 7.
Circ Res. 2018.
PMID: 29880546
Clinical Trial.
From baseline to 6 months, both groups improved in LVEF (+6.93.3% in group A, P=0.001 and +7.13.5% in group B, P=0.001), NT-proBNP (-578211 pg/mL, P=0.02 and -633305 pg/mL, P=0.01), and 6-minute walk test (+8721 m, P=0.03 and +9225 m, P=0.02). In contrast, we observ …
From baseline to 6 months, both groups improved in LVEF (+6.93.3% in group A, P=0.001 and +7.13.5% in group B, P=0.001), NT-proBNP (-578211 …
Item in Clipboard
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure.
Poglajen G, Zemljič G, Cerar A, Frljak S, Jaklič M, Androcec V, Vrtovec B.
Poglajen G, et al.
Cell Transplant. 2019 Jul;28(7):856-863. doi: 10.1177/0963689719840351. Epub 2019 May 2.
Cell Transplant. 2019.
PMID: 31046425
Free PMC article.
The average serum creatinine was 9126 mol/L, serum bilirubin 189 mol/L, NT-proBNP 1767 (468, 2446) pg/mL, LVEF 279% and 6' walk test 442123 m. The average scar burden in patients with nonischemic and ischemic DCM was 5815% and 5125% (P=0.48). ...
The average serum creatinine was 9126 mol/L, serum bilirubin 189 mol/L, NT-proBNP 1767 (468, 2446) pg/mL, LVEF 279% and 6' walk test 442123 …
Item in Clipboard
Cite
Cite